Pharmacy benefit management

By not prioritizing the use of pharmacy benefit management drug rebates, the administration is hurting companies, who shoulder the burden of rising costs by all stakeholders in the supply chain.

The president will propose a sweeping effort to bring down U.S. drug prices in a plan to make good on a campaign promise.

The price of prescriptions has skyrocketed and the industry needs to address matters sooner rather than later.

The price of prescriptions has skyrocketed and the industry needs to address matters sooner rather than later.

Many pharmacy benefit managers promote discounts and drug rebates that may look good on paper, but often provide no transparency of true costs. This can result in employers paying much more than they should.

Many pharmacy benefit managers promote discounts and drug rebates that may look good on paper, but often provide no transparency of true costs. This can result in employers paying much more than they should.

By tying its clinical database to physicians’ EHR systems, the drug chain hopes to avoid patient sticker shock and prescription abandonment at the point of sale.

The changing dynamics of carrier competition, the effect of insurance M&A on the market and influence on prescription drug availability are all ways employer-based healthcare may be impacted.

By tying its clinical database to physicians’ EHR systems, the drug chain hopes to avoid patient sticker shock and prescription abandonment at the point of sale.

Three hundred large hospital systems are teaming up to control rising drug costs. But even their firepower might not be enough.